Oneness Biotech Co (LUX:ONEA) COGS-to-Revenue : 0.37 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co COGS-to-Revenue?

Oneness Biotech Co's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.31 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.81 Mil.

Oneness Biotech Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.37.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Oneness Biotech Co's Gross Margin % for the three months ended in Mar. 2024 was 62.53%.

Oneness Biotech Co COGS-to-Revenue Historical Data

The historical data trend for Oneness Biotech Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co COGS-to-Revenue Chart

Oneness Biotech Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.54

1.26

0.26

0.32

0.21

Oneness Biotech Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.75	0.52	0.68	0.64	0.37

Oneness Biotech Co COGS-to-Revenue Calculation

Oneness Biotech Co's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.215	/	34.762
	=	0.21

Oneness Biotech Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.305	/	0.814
	=	0.37

Oneness Biotech Co (LUX:ONEA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Oneness Biotech Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.305 / 0.814
	=	62.53 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Oneness Biotech Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Oneness Biotech Co (LUX:ONEA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

4743:Taiwan

Address

No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106

Website

https://www.onenessbio.com.tw

Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines